Persistent URL of this record https://hdl.handle.net/1887/103587
In Collections
This item can be found in the following collections:
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-alpha Antagonist
- All authors
- Genovese, M.C.; Heijde, D.M. van der; Keystone, E.C.; Spindler, A.J.; Benhamou, C.; Kavanaugh, A.; Fudman, E.; Lampl, K.; O'Brien, C.; Duffield, E.L.; Poiley, J.; Weinblatt, M.E.
- Date
- 2014-11-30
- Journal
- Journal of Rheumatology
- Volume
- 41
- Issue
- 11
- Pages
- 2120 - 2128